Cargando…
TRAP5b and RANKL/OPG Predict Bone Pathology in Patients with Gaucher Disease
Background and objective: Bone involvement occurs in 75% of patients with Gaucher disease (GD), and comprises structural changes, debilitating pain, and bone density abnormalities. Osteoporosis is a silent manifestation of GD until a pathologic fracture occurs. Thus, early diagnosis is crucial for i...
Autores principales: | Ivanova, Margarita, Dao, Julia, Noll, Lauren, Fikry, Jacqueline, Goker-Alpan, Ozlem |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8160801/ https://www.ncbi.nlm.nih.gov/pubmed/34065531 http://dx.doi.org/10.3390/jcm10102217 |
Ejemplares similares
-
Wnt signaling pathway inhibitors, sclerostin and DKK-1, correlate with pain and bone pathology in patients with Gaucher disease
por: Ivanova, Margarita M., et al.
Publicado: (2022) -
Cellular and biochemical response to chaperone versus substrate reduction therapies in neuropathic Gaucher disease
por: Ivanova, Margarita M., et al.
Publicado: (2021) -
Optimal therapy in Gaucher disease
por: Goker-Alpan, Ozlem
Publicado: (2010) -
Biofabrication of an in-vitro bone model for Gaucher disease
por: Banerjee, Dishary, et al.
Publicado: (2023) -
Rapid Clathrin-Mediated Uptake of Recombinant α-Gal-A to Lysosome Activates Autophagy
por: Ivanova, Margarita M., et al.
Publicado: (2020)